Skip to main content

Table 2 Overview of tumour stage, diagnosis duration, Karnofsky performance index, haemoglobin and therapy

From: Reliability and validity of a new scale on internal coherence (ICS) of cancer patients

  Study 1: Cancer group Study 2: BC CRC
Metastasis or generalised stage     
yes 35 (61.4%)   2 3
No 24 (38.6%) Stage 1 3 0
   Stage 2 8 2
   Stage 3 4 18
   missing 0 2
Initial diagnosis (years) Initial diagnosis (months)
Mean (SD) 2.9 (3.1)   1.3 (1.0) 1.4 (0.5)
Median 2.0   1.0 1.0
Min/Max 0/12   1/5 1/2
Karnofsky-Index (%)     
Mean (SD) 81.8 (11.6)   86.7 (10.5) 88.7 (9.2)
Median 90   90 90
Haemoglobin (gr/dl)     
Mean (SD) 12.1 (1.84)   13.0 (1.28) 13.7 (6.8)
Median 12.5   13.2 12.65
Anemia (<12) 22 (38.5%)   2 (11.1%) 9 (36.0%)
Therapies at the point of questioning Therapies after first questioning
Operation because of cancer 39 (68.4%)   14 (82.3%) 25 (100%)
Chemotherapy 31 (54.4%)   17 (100%) 25 (100%)
Chemotherapy Scheme     
CMF+RAD    2  
EC or EC+RAD    7  
EC/CMF or EC/CMF +RAD    3  
FEC or FEC + RAD    1  
EC/Tac    2  
Tac/other    2  
5FU (Mayo mod/Ardalan)     5
5FU + RAD     5
FOLFOX     12
FOLFOX+RAD     1
OXALI mono or others     2
Radiotherapy 14 (24.6%)   6 (35.2%) 7 (28.0%)
Antihormonal therapy 13 (22.8%)   6 (35.2%) 0 (0)
Mistletoe therapy 57 (100%)   17 (100) 25 (100)